MeSH tree: D12.776.124.125.662
For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase before endovascular thrombectomy is associated with higher functional independence at 90 days, according ...
May 25, 2025
0
21
A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at treating ischemic stroke than existing therapies.
Apr 29, 2025
0
11
For patients with mainly mild posterior circulation ischemic stroke who do not receive thrombectomy, alteplase administered at 4.5 to 24 hours after onset results in higher frequency of functional independence at 90 days ...
Apr 4, 2025
0
19
Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.
Apr 3, 2025
0
20
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold significant advantages ...
Mar 13, 2025
0
18
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Mar 6, 2025
0
16
The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and Lancet Neurology—the ...
Feb 18, 2025
0
17
For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful thrombectomy results in improved likelihood of excellent outcome (modified Rankin scale score 0 to ...
Feb 18, 2025
0
8
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented ...
Feb 8, 2025
0
20
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days after their stroke than ...
Feb 8, 2025
0
22
